Table 2 Significantly differentially expressed genes (FDR ≤ 5 × 10−6) as: AD+/GBM+/LC−, AD−/GBM−/LC+, AD+/GBM−/LC−, AD−/GBM+/LC+, AD−/GBM−/LC− and AD+/GBM+/LC+.

From: A molecular hypothesis to explain direct and inverse co-morbidities between Alzheimer’s Disease, Glioblastoma and Lung cancer

AD+/GBM+/LC−

AD−/GBM−/LC+

AD−/GBM−/LC−

AD+/GBM+/LC+

NFKBIA

EMP3

PFN2

KCNK1

B3GNT1

CX3CL1

SPP1

CEBPD

EMP1

ENO2

NMNAT2

OLFM1

NTRK3

DDIT4

S100A10

TRIP10

STMN2

DOCK3

RTN3

RND1

PLOD3

CDKN1A

TNFAIP3

UCHL1

GABBR2

TCEAL2

PLK2

UNG

CSDA

GIMAP4

SCG5

LRRC20

MOAP1

PPL

PPP1R14BP3

PXDC1

MYO1F

WASF1

SEMA4F

TSPAN7

HLF

GTF2IRD1

BCL6

CD163

INA

UNC13A

RTN1

TMEM246

TIMP1

ID3

IL10RA

TUBA4A

PORCN

PEBP1

PRKCB

CHI3L1

FCGRT

S100A4

PGBD5

DLG3

PRKCZ

CD200

INHBB

HLA-DMB

DOCK6

SULT4A1

NELL1

MAST3

RP11-287D1.3

ABCB7

ANXA2P2

CTSS

SCAMP5

FBXO41

GPRASP1

BCAS3

RHBDF2

TSPO

SOCS3

RAB15

RFPL1-AS1

NDRG4

PTK2B

CDKN2C

MYD88

CCR1

HPRT1

HOOK1

NDN

REPS2

PLP2

VSIG4

TRAF3IP2

NDUFS2

CGREF1

NCALD

ELMO1

SLC35F2

VEZF1

HERC5

KIF3C

ACTL6B

SNRPN

PEG3

BACE2

PIEZO1

TCF7L1

EEF1A2

RP11-18A3.4

NRN1

PIP5K1B

FAM60A

ARHGDIB

ZNF516

CKMT1B

TTC9

REEP1

SHANK2

PPIC

CFLAR

LCAT

FNDC4

CNTNAP2

BEX4

SMARCA2

ZNF217

MSX1

TGFB1I1

CDK5

CABYR

LDB2

C2CD2L

TP53

LAMB2

FAM129A

STX1A

RAB3B

MICU1

EPB41L3

CASP6

SRGN

PLBD1

LAMP5

RGS7

CCK

TMEM35

KCNE4

TRIM22

GBP1P1

SEZ6L2

RP11-430B1.2

NAP1L2

KCNAB1

AD−/GBM+/LC+

DDR2

SP100

GOT1

SYNDIG1

SNCA

CLCN4

SNRPEP4

C3AR1

ANG

CDH18

TMEM59L

GABARAPL1

CHRM3

SEC61G

RAB20

ECM2

OGDHL

ATP13A2

MEF2C

HAS1

AIMP2

ITGA5

CD58

SH3BP1

SPINT2

APBB1

HSPB3

FTSJ2

STAB1

FLI1

AD+/GBM−/LC−

 

RUNX1T1

CRY2

METTL1

ARHGEF40

C5AR1

RAPGEF3

 

CYFIP2

TYRP1

RP11-77H9.2

SLC7A7

LYZ

SLC6A12

   

WDHD1

CD44

MSR1